The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC 157: Separating Fact from Fiction in Soft Tissue Injury Treatment Erik Schraga posted on the topic LinkedIn Peptide BPC 157 Does It Work? Breaking Down the Evidence and the Hype BPC 157 has already hit the mainstream, but should it hit your bloodstream?